GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bora Pharmaceuticals Co Ltd (TPE:6472) » Definitions » Price-to-Owner-Earnings

Bora Pharmaceuticals Co (TPE:6472) Price-to-Owner-Earnings : 23.15 (As of May. 25, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Bora Pharmaceuticals Co Price-to-Owner-Earnings?

As of today (2025-05-25), Bora Pharmaceuticals Co's share price is NT$778.00. Bora Pharmaceuticals Co's Owner Earnings per Share (TTM) ended in Mar. 2025 was NT$33.60. It's Price-to-Owner-Earnings for today is 23.15.


The historical rank and industry rank for Bora Pharmaceuticals Co's Price-to-Owner-Earnings or its related term are showing as below:

TPE:6472' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.89   Med: 23.62   Max: 223.41
Current: 23.33

During the past 13 years, the highest Price-to-Owner-Earnings of Bora Pharmaceuticals Co was 223.41. The lowest was 8.89. And the median was 23.62.


TPE:6472's Price-to-Owner-Earnings is ranked better than
53.59% of 446 companies
in the Drug Manufacturers industry
Industry Median: 24.885 vs TPE:6472: 23.33

As of today (2025-05-25), Bora Pharmaceuticals Co's share price is NT$778.00. Bora Pharmaceuticals Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$41.83. Therefore, Bora Pharmaceuticals Co's PE Ratio (TTM) for today is 18.60.

As of today (2025-05-25), Bora Pharmaceuticals Co's share price is NT$778.00. Bora Pharmaceuticals Co's EPS without NRI for the trailing twelve months (TTM) ended in was NT$40.26. Therefore, Bora Pharmaceuticals Co's PE Ratio without NRI for today is 19.32.

During the past 13 years, Bora Pharmaceuticals Co's highest PE Ratio without NRI was 469.96. The lowest was 11.96. And the median was 28.51.


Bora Pharmaceuticals Co Price-to-Owner-Earnings Historical Data

The historical data trend for Bora Pharmaceuticals Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bora Pharmaceuticals Co Price-to-Owner-Earnings Chart

Bora Pharmaceuticals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.49 18.68 22.29 26.20 62.32

Bora Pharmaceuticals Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.56 125.36 31.44 62.32 20.09

Competitive Comparison of Bora Pharmaceuticals Co's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Bora Pharmaceuticals Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bora Pharmaceuticals Co's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bora Pharmaceuticals Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Bora Pharmaceuticals Co's Price-to-Owner-Earnings falls into.


;
;

Bora Pharmaceuticals Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Bora Pharmaceuticals Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=778.00/33.60
=23.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bora Pharmaceuticals Co  (TPE:6472) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Bora Pharmaceuticals Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Bora Pharmaceuticals Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Bora Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Aly. 36, Lane 26, Ruiguang Road, 6th Floor, Neihu District, Taipei, TWN, 114
Bora Pharmaceuticals Co Ltd is a pharmaceutical company based in Taiwan. It covers the pharmaceutical supply chain from research and development to sales and distribution. The main activities of the Company focus on manufacturing and selling generic, brand, and over-the-counter (OTC) drugs, contract development and manufacturing (CDMO), and developing and selling consumer healthcare products. The Group operates in three reportable segments; Commercial sales segment, Contract Development & Manufacturing Organization segment, and Other segment. The majority of revenue is derived from the Commercial sales segment. Geographically, the company operates in the USA which derives key revenue, Europe, Taiwan, and other regions.

Bora Pharmaceuticals Co Headlines

No Headlines